Tepe, Gunnar
Wang, John
Corpataux, Jean-Marc
Pua, Uei
Binkert, Christoph A.
Moscovic, Matej
Ghotbi, Reza
Keirse, Koen
Robertson, Donald
Brodmann, Marianne
Clinical trials referenced in this document:
Documents that mention this clinical trial
BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries
https://doi.org/10.1007/s00270-020-02586-3
Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis
https://doi.org/10.1007/s00270-022-03135-w
Article History
Received: 12 March 2020
Accepted: 26 June 2020
First Online: 22 September 2020
Change Date: 11 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00270-021-02861-x
Compliance with Ethical Standards
:
: All authors are clinical investigators of the BIOLUX P-III registry. Gunnar Tepe reports study support by B. Braun, BARD, Bayer, Biotronik, BSC, Gore, Medtronic, Phillips, Verian. Marianne Brodmann receives honoraria from Abbott Vascular, Biotronik, Philips-Spectranetics, Medtronic, Daiichi Sankyo, Bayer Healthcare and BD Bard, acts as a consultant for Boston Scientific Corp., Medtronic, Spectranetics, Intact Vascular, Shockwave, Bayer, Vesper Medical and BD Bard, and receives study support by 480 biomedical, BD Bard, Biotronik, Medtronic, Philips, Shockwave, Med Alliance, Intact Vascular and B. Braun. Christoph Binkert acts as a consultant for Merit Medical and receives research support by Philips/ Profound and Abbott. The other authors declare that they have no conflict of interest.
: All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: For this type of study consent for publication is not required.